Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
Launched by ADVANCED RECONSTRUCTIVE SURGERY ALLIANCE · Feb 5, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patients feel and what their experiences are after undergoing a specific surgery called phrenic nerve reconstruction. This surgery is meant to help people who have diaphragmatic paralysis, a condition that can make it hard to breathe and cause chest pain. The researchers want to understand how this treatment affects patients and their overall quality of life.
To participate in this trial, you need to be diagnosed with diaphragmatic paralysis and scheduled for the phrenic nerve surgery. The study is open to adults aged 65 to 74, as well as those between 25 and 66, regardless of gender. If you decide to join, you can expect to share your thoughts and experiences about the surgery, which will help doctors learn more about its effects on patients. It's important to note that only individuals who understand English can take part in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with a confirmed diagnosis of Diaphragmatic Paralysis.
- • Individuals who are scheduled to undergo phrenic nerve reconstructive surgery for the treatment of Diaphragmatic Paralysis.
- Exclusion Criteria:
- • - Individuals who do not comprehend the English language.
About Advanced Reconstructive Surgery Alliance
The Advanced Reconstructive Surgery Alliance (ARSA) is a leading clinical trial sponsor dedicated to advancing the field of reconstructive surgery through innovative research and collaboration. Committed to enhancing patient outcomes, ARSA focuses on developing and evaluating cutting-edge surgical techniques and technologies. By fostering partnerships with healthcare professionals, academic institutions, and industry leaders, the alliance aims to translate scientific discoveries into effective clinical practices, ensuring that patients receive the highest standard of care in reconstructive procedures.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shrewsbury, New Jersey, United States
Red Bank, New Jersey, United States
Patients applied
Trial Officials
Matthew Kaufman, MD.
Principal Investigator
Advanced Reconstructive Surgery Alliance
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported